Hims & Hers Health, Inc.

Equities

HIMS

US4330001060

Healthcare Facilities & Services

Market Closed - Nyse Other stock markets 01:30:02 18/05/2024 am IST			5-day change	1st Jan Change
14.57 ^USD	+3.77%		+18.55%	+63.71%

16/05	Hims & Hers Health, Inc. Appoints Anja Manuel to its Board of Directors	CI
07/05	Sector Update: Consumer Stocks Mixed Pre-Bell Tuesday	MT

Hims & Hers Health, Inc. Announces Impairment Charges for the First Quarter Ended March 31, 2024

May 07, 2024 at 01:35 am IST

Hims & Hers Health, Inc. announced impairment charges for the first quarter ended March 31, 2024. For the quarter, the company reported impairment of long-lived assets of $75,000 against $429,000 a year ago.

Latest news about Hims & Hers Health, Inc.

Hims & Hers Health, Inc. Appoints Anja Manuel to its Board of Directors	16/05	CI
Sector Update: Consumer Stocks Mixed Pre-Bell Tuesday	07/05	MT
Piper Sandler Adjusts Hims & Hers Health's Price Target to $13 From $11, Keeps Neutral Rating	07/05	MT
Sector Update: Consumer	07/05	MT
Deutsche Bank Adjusts Hims & Hers Health Price Target to $16 From $14, Maintains Hold Rating	07/05	MT
Exchange-Traded Funds Lower, Equity Futures Mixed Pre-Bell Tuesday as Traders Assess Earnings	07/05	MT
Social Buzz: Wallstreetbets Stocks Mostly Lower Pre-Bell Tuesday; Palantir to Decline, Hims & Hers Health to Advance	07/05	MT
Hims & Hers Health Swings to Q1 Earnings, Revenue Rises	07/05	MT
Transcript : Hims & Hers Health, Inc., Q1 2024 Earnings Call, May 06, 2024	07/05
Earnings Flash (HIMS) HIMS & HERS HEALTH Posts Q1 Revenue $278.2M, vs. Street Est of $268.7M	07/05	MT
Hims & Hers Health, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	07/05	CI
Hims & Hers Health, Inc. Announces Impairment Charges for the First Quarter Ended March 31, 2024	07/05	CI
Hims & Hers Health, Inc. Provides Revenue Guidance for the Second Quarter and Full Year of 2024	07/05	CI
Social Buzz: Wallstreetbets Stocks Mixed Pre-Bell Monday; Palantir to Advance, Trump Media & Technology Group to Decline	06/05	MT
Hims & Hers Health Insider Sold Shares Worth $4,200,307, According to a Recent SEC Filing	06/05	MT
Seaport Global Starts Hims & Hers Health With Buy Rating	26/04	MT
Jefferies Downgrades Hims & Hers Health to Hold From Buy, Cuts Price Target to $15 From $17	16/04	MT
Canaccord Genuity Initiates Coverage on Hims & Hers Health With Buy Rating, $20 Price Target	10/04	MT
Hims & Hers Appoints Christopher Payne as Newest Board Member	03/04	CI
Hims & Hers Health Insider Sold Shares Worth $823,055, According to a Recent SEC Filing	22/03	MT
Hims & Hers Health Insider Sold Shares Worth $965,016, According to a Recent SEC Filing	16/03	MT
Hims & Hers Health Insider Sold Shares Worth $500,107, According to a Recent SEC Filing	08/03	MT
Hims & Hers Health Insider Sold Shares Worth $685,288, According to a Recent SEC Filing	06/03	MT
Hims & Hers Health Insider Sold Shares Worth $5,032,142, According to a Recent SEC Filing	05/03	MT
Tigress Financial Boosts Price Target on Hims & Hers Health to $19 From $15, Cites Move to Accelerated Growth Phase, Keeps Buy Rating	01/03	MT

Chart Hims & Hers Health, Inc.

Duration

Period

More charts

Company Profile

Hims & Hers Health, Inc. provides a consumer-first platform, which helps customers to fulfill their health and wellness needs. The Companyâs digital platform offers access to a provider network, a clinically focused electronic medical record system, digital prescriptions and cloud pharmacy fulfillment. Its digital platform provides access to treatments for a range of conditions, including those related to sexual health, hair loss, dermatology, mental health and weight loss. The Company connects patients to licensed healthcare professionals who can prescribe medications when appropriate. In addition, the Company also offers access to a range of health and wellness products designed to meet individual needs, which includes curated prescription and non-prescription products. Its Hims & Hers mobile application enables consumers to access a range of educational programs, wellness content, community support and other services that promote lifelong health and wellness.

Sector

Healthcare Facilities & Services

Calendar

06/06/2024 - Annual General Meeting

Related indices

Russell 2000

More about the company

Income Statement Evolution

More financial data

Ratings for Hims & Hers Health, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

14.57 USD

Average target price

16.33 USD

Spread / Average Target

+12.06%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Telemedicine Services

	1st Jan change	Capi.
HIMS & HERS HEALTH, INC.	+63.71%	3.13B
TELADOC HEALTH, INC.	-40.93%	2.16B
QDM INTERNATIONAL INC.	+115.18%	703M
TALKSPACE, INC.	+8.27%	467M
AMERICAN WELL CORPORATION	-67.19%	145M
SHL TELEMEDICINE LTD.	-32.23%	85.06M

Telemedicine Services